This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.
A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control. Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.
Study Type
OBSERVATIONAL
Enrollment
200
Quality of Care
University Medical Center Groningen
Groningen, Netherlands
RECRUITINGhealth related quality of life
health related quality of life with EQ-5D questionnaire at 6 and 12 months
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.